

| Property name | Tool | Property value |
|---|---|---|
| Molecular weight (g/mol) | RDKit | 188.18 |
| Log P | RDKit | 1.6 |
| Topological polar surface area (Å2) | RDKit | 43.37 |
| Number of hydrogen bond acceptors | RDKit | 3 |
| Number of hydrogen bond donors | RDKit | 0 |
| Number of carbon atoms | RDKit | 11 |
| Number of heavy atoms | RDKit | 14 |
| Number of heteroatoms | RDKit | 3 |
| Number of nitrogen atoms | RDKit | 0 |
| Number of sulfur atoms | RDKit | 0 |
| Number of chiral carbon atoms | RDKit | 0 |
| Stereochemical complexity | RDKit | 0 |
| Number of sp hybridized carbon atoms | RDKit | 0 |
| Number of sp2 hybridized carbon atoms | RDKit | 10 |
| Number of sp3 hybridized carbon atoms | RDKit | 1 |
| Shape complexity | RDKit | 0.09 |
| Number of rotatable bonds | RDKit | 1 |
| Number of aliphatic carbocycles | RDKit | 1 |
| Number of aliphatic heterocycles | RDKit | 0 |
| Number of aliphatic rings | RDKit | 1 |
| Number of aromatic carbocycles | RDKit | 1 |
| Number of aromatic heterocycles | RDKit | 0 |
| Number of aromatic rings | RDKit | 1 |
| Total number of rings | RDKit | 2 |
| Number of saturated carbocycles | RDKit | 0 |
| Number of saturated heterocycles | RDKit | 0 |
| Number of saturated rings | RDKit | 0 |
| Number of Smallest Set of Smallest Rings (SSSR) | RDKit | 2 |

| Property name | Tool | Property value |
|---|---|---|
| Number of Lipinski’s rule of 5 violations | RDKit | 0 |
| Lipinski’s rule of 5 filter | RDKit | Passed |
| Number of Ghose filter violations | RDKit | 0 |
| Ghose filter | RDKit | Passed |
| Veber filter | RDKit | Good |
| Pfizer 3/75 filter | RDKit | Bad |
| GSK 4/400 filter | RDKit | Good |
| Weighted quantitative estimate of drug-likeness (QEDw) score | RDKit | 0.671797 |

| Property name | Tool | Property value |
|---|---|---|
| Bioavailability score | SwissADME | 0.85 |
| Solubility class [ESOL] | SwissADME | Soluble |
| Solubility class [Silicos-IT] | SwissADME | Soluble |
| Blood Brain Barrier permeation | SwissADME | Yes |
| Gastrointestinal absorption | SwissADME | High |
| Log Kp (Skin permeation, cm/s) | SwissADME | -6.49 |
| Number of PAINS structural alerts | SwissADME | 1 |
| Number of Brenk structural alerts | SwissADME | 0 |
| CYP1A2 inhibitor | SwissADME | Yes |
| CYP2C19 inhibitor | SwissADME | No |
| CYP2C9 inhibitor | SwissADME | No |
| CYP2D6 inhibitor | SwissADME | No |
| CYP3A4 inhibitor | SwissADME | No |
| P-glycoprotein substrate | SwissADME | No |

| IMPPAT target identifier | Gene identifier | HGNC symbol | Entrez Gene identifier | Source |
|---|---|---|---|---|
| TAR_EXP_000083 | ENSG00000135346 | CGA | 1081 | NPASS |
| TAR_EXP_000119 | ENSG00000101751 | POLI | 11201 | ChEMBL, NPASS |
| TAR_EXP_000433 | ENSG00000168496 | FEN1 | 2237 | ChEMBL, NPASS |
| TAR_EXP_000475 | ENSG00000120948 | TARDBP | 23435 | NPASS |
| TAR_EXP_000604 | ENSG00000112164 | GLP1R | 2740 | NPASS |
| TAR_EXP_000747 | ENSG00000138413 | IDH1 | 3417 | ChEMBL, NPASS |
| TAR_EXP_000766 | ENSG00000131203 | IDO1 | 3620 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_000966 | ENSG00000116044 | NFE2L2 | 4780 | ChEMBL, NPASS |
| TAR_EXP_001031 | ENSG00000112312 | GMNN | 51053 | ChEMBL, NPASS |
| TAR_EXP_000845 | ENSG00000166949 | SMAD3 | 4088 | ChEMBL, NPASS |
| TAR_EXP_001206 | ENSG00000042088 | TDP1 | 55775 | ChEMBL, NPASS |
| TAR_EXP_001937 | ENSG00000101224 | CDC25B | 994 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_001151 | ENSG00000170734 | POLH | 5429 | NPASS |
| TAR_EXP_001737 | ENSG00000145391 | SETD7 | 80854 | NPASS |
| TAR_EXP_001728 | ENSG00000176208 | ATAD5 | 79915 | ChEMBL, NPASS |
| TAR_EXP_001935 | ENSG00000164045 | CDC25A | 993 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_001663 | ENSG00000162607 | USP1 | 7398 | ChEMBL, NPASS |
| TAR_EXP_001373 | ENSG00000239713 | APOBEC3G | 60489 | NPASS |
| TAR_EXP_001300 | ENSG00000160801 | PTH1R | 5745 | NPASS |
| TAR_EXP_001684 | ENSG00000104267 | CA2 | 760 | ChEMBL, NPASS |